April 2016 - Bioscience Americas

April 2016

Here’s Why the Drug Companies are Fighting Stem Cell Treatments

U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according to a report released by health care information company IMS Health Holdings Inc. on Thursday. Those figures, which take into account anticipated discounts, rebates and other price concessions that have become common, represent an annual growth rate of 4 percent to 7 percent through 2020, according to the report. Using wholesale prices, IMS sees U.S. spending rising [...]

Bioscience Americas is Poised to Lead the Global Medical Tourism Market

Phoenix, April 18, 2016. Bioscience Americas, LLC , the leading international developer of autologous stem cell treatment centers, has positioned itself to capture a significant share of the global medical tourism market. Estimated to reach $120 billion in two years, the market for medical tourism is projected to continue to increase substantially over the next decade. Bioscience Americas and its scientific research partner the Global Institute of Stem Cell Therapy and Research (GIOSTAR) are currently actively involved in implementing autologous, or [...]

422 Million Suffer With Diabetes

The number of adults with diabetes has quadrupled worldwide in under four decades to 422 million, and the condition is fast becoming a major problem in poorer countries, a World Health Organization study showed on Wednesday. In one of the largest studies to date of diabetes trends, the researchers said ageing populations and rising levels of obesity across the world mean diabetes is becoming "a defining issue for global public health". Type 2 diabetes is a long-term condition characterized by insulin [...]

Stem Cell Shows Promise For Heart Failure

Stem cell therapy shows promise for people battling heart failure, a new study finds. The clinical trial found that end-stage heart failure patients treated with stem cells harvested from their own bone marrow had 37 percent fewer cardiac events than those who received a placebo. "For the last 15 years, everyone has been talking about cell therapy and what it can do. These results suggest that it really works," study author and cardiac surgeon Dr. Amit Patel, director of Cardiovascular Regenerative [...]